UpToDate Lexidrug vs MoonBeam3 Cloud Reporting

UpToDate® Lexidrug™ is the preferred drug reference app, providing industry-leading drug information and tools that support safe and effective medication and therapeutic decisions. View the latest clinical information updated daily by our unparalleled multidisciplinary editorial team that continually reviews the most current evidence available. Used and trusted by pharmacists, physicians, nurses, advanced practice nurses, dentists, and students as an invaluable referential resource. Easily access Lexidrug content directly in the app without needing to download databases onto your device. Our mobile packages are designed to support a variety of roles, offering quick access to expert content and capabilities, including: • In-depth drug databases with detailed dosing support • Comprehensive monographs with adverse reactions information • Hundreds of medical calculators • Interactive drug interactions checker • Ability to store database content for offline use New individual users will receive a one-month free trial to the UpToDate Lexidrug Hospital Pharmacist package. At the end of the free trial, users will automatically be billed a subscription fee of $29.99 per month via their iTunes Account for continuing access. To avoid being charged, users must cancel their free trial at least 24 hours before the end of the trial period. Users can manage settings, cancel subscriptions, or turn off auto-renewal anytime during the subscription period via iTunes Account Settings. Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication, where applicable.

The MoonBeam3 Cloud application allows logging data and dashboard presentation / on-going data analytics. The application allows selectable drop down fields that are captured and reported along with system operation. Drop down selection: The program manager may enter in drop-down selectable fields for pre-listing users, location, and specific uses and the user may then later select from among those options when using the device.